Immunotherapy Drug Keytruda Approved For Colon Cancer Patients With Specific Tumor Abnormalities

Updated June 10th, 2021

Immunotherapy Drug Keytruda Approved For Colon Cancer Patients With Specific Tumor Abnormalities

A new option for the treatment of metastatic colorectal cancer, immune checkpoint inhibitor Keytruda, has been approved by the FDA -- marking historic progress for certain patients

NOW
PLAYING
What You Need to Know About Cisplatin Chemotherapy Treatment for Advanced-Stage Bladder Cancer
NOW
PLAYING
New Hope For Some Early-Stage Breast Cancer Patients: FDA Approves Targeted Therapy Drug Verzenio
NOW
PLAYING
What Can Genetics Tell Us About the Molecular Features of a Bladder Cancer Tumor?
NOW
PLAYING
Chemotherapy, Chemoradiation, and Muscle Invasive Bladder Cancer
NOW
PLAYING
It’s National Breast Cancer Awareness Month; Here Are Four Treatment & Screening Advancements Grabbing the Attention of Oncologists
NOW
PLAYING
New Hope for Patients With Cervical Cancer: Adding Immunotherapy Drug to Standard Chemo Treatment Could Improve Survival Time

Treatment: Making Wise Surgery Decisions

SEE MORE   

Treatment: Making Wise Surgery Decisions

There is plenty of marketing information out there about the best surgery techniques, and the best places to have your operation done. Doing your own research is crucial before committing to any treatment.

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.